{"id":105617,"date":"2026-05-28T08:00:00","date_gmt":"2026-05-28T06:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?p=105617"},"modified":"2026-05-26T09:34:34","modified_gmt":"2026-05-26T07:34:34","slug":"pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients","status":"publish","type":"post","link":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","title":{"rendered":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><em>Par Sandra Silvestri, pour Ipsen.com<\/em>&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dans un&nbsp;environnement&nbsp;th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus&nbsp;la fin du&nbsp;parcours:&nbsp;ce n\u2019est que le&nbsp;d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world&nbsp;evidence, RWE), les analyses&nbsp;post\u2011hoc&nbsp;et les&nbsp;\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives&nbsp;pour l\u2019apprentissage scientifique.&nbsp;<br>Chez Ipsen, nous nous engageons&nbsp;\u00e0&nbsp;explorer les questions encore sans r\u00e9ponse et&nbsp;\u00e0&nbsp;produire des donn\u00e9es robustes&nbsp;qui vont&nbsp;au\u2011del\u00e0&nbsp;du d\u00e9veloppement&nbsp;initial&nbsp;du m\u00e9dicament, afin d\u2019apporter une vision&nbsp;plus large et&nbsp;\u00e0 long terme, fond\u00e9e sur des preuves,&nbsp;au service des&nbsp;communaut\u00e9s que nous&nbsp;accompagnons.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Le r\u00f4le croissant des donn\u00e9es en vie r\u00e9elle<\/strong>&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les essais cliniques apportent des r\u00e9ponses scientifiques essentielles, mais par nature, ils ne peuvent pas refl\u00e9ter pleinement la r\u00e9alit\u00e9 du quotidien des patients\u202f: la diversit\u00e9&nbsp;des parcours, la complexit\u00e9&nbsp;des maladies et l\u2019impr\u00e9visibilit\u00e9&nbsp;des prises en charge.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les donn\u00e9es en vie r\u00e9elle&nbsp;contribuent \u00e0&nbsp;combler cet \u00e9cart. Elles rendent compte de ce qui compte r\u00e9ellement pour les&nbsp;personnes concern\u00e9es\u202f: l\u2019efficacit\u00e9&nbsp;d\u2019un traitement sur la dur\u00e9e, sa tol\u00e9rance au quotidien et&nbsp;sa place&nbsp;dans la&nbsp;vie r\u00e9elle&nbsp;avec&nbsp;la&nbsp;maladie. En investissant dans des programmes solides de RWE, nous approfondissons notre compr\u00e9hension des besoins des patients, mesurons l\u2019impact r\u00e9el de nos m\u00e9dicaments et veillons&nbsp;\u00e0&nbsp;ce qu\u2019ils continuent d\u2019apporter des b\u00e9n\u00e9fices&nbsp;concrets&nbsp;aux personnes qui en d\u00e9pendent.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Analyses&nbsp;post<\/strong>\u2011<strong>hoc&nbsp;et essais de phase<\/strong><strong>\u202f<\/strong><strong>IV<\/strong><strong>\u202f<\/strong><strong>: approfondir la compr\u00e9hension l\u00e0&nbsp;c\u2019est essentiel<\/strong>&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les analyses&nbsp;post\u2011hoc&nbsp;et les \u00e9tudes de phase\u202fIV&nbsp;\u2014&nbsp;r\u00e9alis\u00e9es&nbsp;apr\u00e8s l\u2019autorisation d\u2019un m\u00e9dicament&nbsp;\u2014&nbsp;jouent un r\u00f4le tout aussi&nbsp;fondamental.&nbsp;En tenant compte de&nbsp;la diversit\u00e9&nbsp;des patients et la variabilit\u00e9&nbsp;des parcours de soins, nous questionnons&nbsp;des&nbsp;hypoth\u00e8ses afin&nbsp;d\u2019en tirer&nbsp;des enseignements&nbsp;adapt\u00e9s aux&nbsp;d\u00e9fis du monde r\u00e9el.&nbsp;<br>Quel est l\u2019impact de nos m\u00e9dicaments chez des patients pr\u00e9sentant certaines comorbidit\u00e9s ou recevant d\u2019autres traitements\u202f? Quels marqueurs cliniques pourraient m\u00e9riter une exploration approfondie\u202f? Comment&nbsp;l\u2019environnement&nbsp;th\u00e9rapeutique, et par cons\u00e9quent les recommandations de traitement,&nbsp;\u00e9voluent\u2011ils&nbsp;au fil du temps\u202f?&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En adoptant une approche cibl\u00e9e, nous concevons des analyses capables de r\u00e9pondre aux questions les plus&nbsp;importantes&nbsp;pour les&nbsp;professionnels de sant\u00e9&nbsp;comme pour les patients,&nbsp;contribuant ainsi \u00e0 une meilleure compr\u00e9hension de la maladie et \u00e0 une prise en charge toujours plus individualis\u00e9e.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Un avenir fond\u00e9 sur l\u2019apprentissage continu<\/strong>&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les enseignements issus des donn\u00e9es en vie r\u00e9elle, combin\u00e9s \u00e0 la&nbsp;richesse&nbsp;des essais de phase\u202fIV et des analyses&nbsp;post\u2011hoc, offrent une compr\u00e9hension multidimensionnelle et&nbsp;approfondie&nbsp;de l\u2019impact d\u2019un m\u00e9dicament. Pour Ipsen, la g\u00e9n\u00e9ration&nbsp;en continue&nbsp;de donn\u00e9es apr\u00e8s&nbsp;l\u2019autorisation&nbsp;de mise sur le march\u00e9&nbsp;n\u2019est pas&nbsp;un simple compl\u00e9ment\u202f: c\u2019est un engagement. Un engagement&nbsp;\u00e0&nbsp;comprendre&nbsp;pleinement&nbsp;l\u2019impact de nos m\u00e9dicaments, non seulement pour le plus grand nombre, mais aussi pour chaque individu,&nbsp;avec ses particularit\u00e9s, qui m\u00e9rite des r\u00e9ponses&nbsp;\u00e0 ses questions.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019avenir de la prise en charge des patients reposera sur cette culture de l\u2019apprentissage continu. L\u2019autorisation d\u2019un m\u00e9dicament est une \u00e9tape importante,&nbsp;qui m\u00e9rite&nbsp;d\u2019\u00eatre c\u00e9l\u00e9br\u00e9e, mais elle ne marque pas la fin du parcours. Chaque donn\u00e9e issue du monde r\u00e9el, chaque r\u00e9sultat \u00e0 long terme, chaque analyse&nbsp;post\u2011autorisation&nbsp;nous rapproche&nbsp;d\u2019une optimisation des soins&nbsp;pour les patients qui en ont le plus besoin.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Notre ambition est claire\u202f: faire en sorte que le progr\u00e8s scientifique ne s\u2019arr\u00eate pas&nbsp;\u00e0&nbsp;l\u2019autorisation, mais&nbsp;qu\u2019il s\u2019acc\u00e9l\u00e8re&nbsp;gr\u00e2ce \u00e0 elle&nbsp;\u2014&nbsp;afin que chaque patient b\u00e9n\u00e9ficie non seulement&nbsp;d\u2019une innovation th\u00e9rapeutique,&nbsp;qui continue d\u2019\u00e9voluer&nbsp;gr\u00e2ce \u00e0&nbsp;de&nbsp;nouvelles donn\u00e9es,&nbsp;une approche cibl\u00e9e&nbsp;et&nbsp;une raison d\u2019\u00eatre.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Par Sandra Silvestri, pour Ipsen.com&nbsp; Dans un&nbsp;environnement&nbsp;th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus&nbsp;la fin du&nbsp;parcours:&nbsp;ce n\u2019est que<\/p>\n","protected":false},"author":11,"featured_media":105613,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[81827],"tags":[],"class_list":["post-105617","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science-2","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global<\/title>\n<meta name=\"description\" content=\"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global\" \/>\n<meta property=\"og:description\" content=\"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T06:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1082\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"heloisedetouchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"heloisedetouchet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\"},\"author\":{\"name\":\"heloisedetouchet\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/person\\\/2c275168b31beee81688f3c041877318\"},\"headline\":\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0\",\"datePublished\":\"2026-05-28T06:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\"},\"wordCount\":836,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"articleSection\":[\"Science\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\",\"name\":\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"datePublished\":\"2026-05-28T06:00:00+00:00\",\"description\":\"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"width\":1082,\"height\":620},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Ipsengroup\",\"https:\\\/\\\/x.com\\\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/person\\\/2c275168b31beee81688f3c041877318\",\"name\":\"heloisedetouchet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"caption\":\"heloisedetouchet\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global","description":"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","og_locale":"fr_FR","og_type":"article","og_title":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global","og_description":"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0","og_url":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","og_site_name":"Global","article_published_time":"2026-05-28T06:00:00+00:00","og_image":[{"width":1082,"height":620,"url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","type":"image\/jpeg"}],"author":"heloisedetouchet","twitter_card":"summary_large_image","twitter_creator":"@ipsengroup","twitter_site":"@ipsengroup","twitter_misc":{"Written by":"heloisedetouchet","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/"},"author":{"name":"heloisedetouchet","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/2c275168b31beee81688f3c041877318"},"headline":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0","datePublished":"2026-05-28T06:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/"},"wordCount":836,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","articleSection":["Science"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","url":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","name":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","datePublished":"2026-05-28T06:00:00+00:00","description":"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","width":1082,"height":620},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/2c275168b31beee81688f3c041877318","name":"heloisedetouchet","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","caption":"heloisedetouchet"}}]}},"jetpack_featured_media_url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/105617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/comments?post=105617"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/105617\/revisions"}],"predecessor-version":[{"id":105618,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/105617\/revisions\/105618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/105613"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=105617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=105617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=105617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}